Jeff Yordon

Jeffrey M.
Yordon was the founder of American Pharmaceutical Partners, Inc. (founded in 1996) where he held the title of President, Co-Chief Operating Officer & Director.
He was also the founder of Sagent Pharmaceuticals, Inc. (founded in 2006) where he held the title of Chairman, President & Chief Executive Officer.
Additionally, he is the founder of Avenacy, Inc. (founded in 2023) where he currently holds the title of Chief Executive Officer.
Mr. Yordon is also the founder of Yorpharm, Inc. Mr. Yordon's current job is Chairman at Northern Illinois University Foundation.
Mr. Yordon's former jobs include Chief Executive Officer at Alpharma Specialty Pharma LLC, Chairman, President & Chief Executive Officer at Sagent Holdings Co., President & Chief Executive Officer at Faulding Pharmaceuticals Plc, Chairman at Fresenius Kabi Canada Ltd., Chairman at Drug Source Co. LLC, Director at Drug, Chemical & Associated Technologies Association, Inc., COO & President-Athenex Pharmaceutical Division at Athenex, Inc., Chief Operating Officer at Gensia Pharmaceuticals, Inc., President & Executive Vice President at Lyphomed, Inc., and Executive Vice President at Gensia Laboratories Ltd. Mr. Yordon's education history includes an undergraduate degree from Northern Illinois University.